• Je něco špatně v tomto záznamu ?

Consensus-based recommendations for the management of juvenile dermatomyositis

FB. Enders, B. Bader-Meunier, E. Baildam, T. Constantin, P. Dolezalova, BM. Feldman, P. Lahdenne, B. Magnusson, K. Nistala, S. Ozen, C. Pilkington, A. Ravelli, R. Russo, Y. Uziel, M. van Brussel, J. van der Net, S. Vastert, LR. Wedderburn, N....

. 2017 ; 76 (2) : 329-340. [pub] 20160811

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu konsensus - konference, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023781
E-zdroje Online Plný text

NLK ProQuest Central od 1939-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 1939-01-01 do Před 6 měsíci
Family Health Database (ProQuest) od 1939-01-01 do Před 6 měsíci

BACKGROUND: In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile dermatomyositis (JDM) is a rare disease within the group of paediatric rheumatic diseases (PRDs) and can lead to significant morbidity. Evidence-based guidelines are sparse and management is mostly based on physicians' experience. Consequently, treatment regimens differ throughout Europe. OBJECTIVES: To provide recommendations for diagnosis and treatment of JDM. METHODS: Recommendations were developed by an evidence-informed consensus process using the European League Against Rheumatism standard operating procedures. A committee was constituted, consisting of 19 experienced paediatric rheumatologists and 2 experts in paediatric exercise physiology and physical therapy, mainly from Europe. Recommendations derived from a validated systematic literature review were evaluated by an online survey and subsequently discussed at two consensus meetings using nominal group technique. Recommendations were accepted if >80% agreement was reached. RESULTS: In total, 7 overarching principles, 33 recommendations on diagnosis and 19 recommendations on therapy were accepted with >80% agreement among experts. Topics covered include assessment of skin, muscle and major organ involvement and suggested treatment pathways. CONCLUSIONS: The SHARE initiative aims to identify best practices for treatment of patients suffering from PRD. Within this remit, recommendations for the diagnosis and treatment of JDM have been formulated by an evidence-informed consensus process to produce a standard of care for patients with JDM throughout Europe.

2nd Department of Pediatrics Semmelweis Hospital Budapest Hungary

Alder Hey Children's NHS Foundation Trust Liverpool UK

Centre for Adolescent Rheumatology Institute of Child Health University College London London UK

Department for Immunology Hematology and Pediatric Rheumatology Necker Hospital APHP Institut IMAGINE Paris France

Department of Paediatrics Hacettepe University Faculty of Medicine Ankara Turkey

Department of Paediatrics Meir Medical Center Sackler School of Medicine Tel Aviv University Tel Aviv Israel

Department of Pediatric Immunology Wilhelmina Children's Hospital University Medical Centre Utrecht Utrecht The Netherlands

Department of Pediatric Immunology Wilhelmina Children's Hospital University Medical Centre Utrecht Utrecht The Netherlands Division of Allergology Immunology and Rheumatology Department of Pediatrics University Hospital Lausanne Switzerland

Department of Pediatric Rheumatology Children's Hospital Helsinki University Central Hospital Helsinki Finland

Division of Pediatrics Child Development and Exercise Center Wilhelmina Children's Hospital University Medical Center Utrecht Utrecht The Netherlands

Division of Rheumatology The Hospital for Sick Children University of Toronto Toronto Ontario Canada

Paediatric Rheumatology Unit Astrid Lindgren Children's Hospital Karolinska University Hospital Stockholm Sweden

Paediatric Rheumatology Unit Department of Paediatrics and Adolescent Medicine General University Hospital and 1st Faculty of Medicine Charles University Prague Praha Czech Republic

Service of Immunology and Rheumatology Hospital de Pediatría Garrahan Buenos Aires Argentina

Università degli Studi di Genova and Istituto Giannina Gaslini Genoa Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023781
003      
CZ-PrNML
005      
20170720123553.0
007      
ta
008      
170720s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/annrheumdis-2016-209247 $2 doi
035    __
$a (PubMed)27515057
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Enders, Felicitas Bellutti $u Department of Pediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands. Division of Allergology, Immunology and Rheumatology, Department of Pediatrics, University Hospital, Lausanne, Switzerland.
245    10
$a Consensus-based recommendations for the management of juvenile dermatomyositis / $c FB. Enders, B. Bader-Meunier, E. Baildam, T. Constantin, P. Dolezalova, BM. Feldman, P. Lahdenne, B. Magnusson, K. Nistala, S. Ozen, C. Pilkington, A. Ravelli, R. Russo, Y. Uziel, M. van Brussel, J. van der Net, S. Vastert, LR. Wedderburn, N. Wulffraat, LJ. McCann, A. van Royen-Kerkhof,
520    9_
$a BACKGROUND: In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile dermatomyositis (JDM) is a rare disease within the group of paediatric rheumatic diseases (PRDs) and can lead to significant morbidity. Evidence-based guidelines are sparse and management is mostly based on physicians' experience. Consequently, treatment regimens differ throughout Europe. OBJECTIVES: To provide recommendations for diagnosis and treatment of JDM. METHODS: Recommendations were developed by an evidence-informed consensus process using the European League Against Rheumatism standard operating procedures. A committee was constituted, consisting of 19 experienced paediatric rheumatologists and 2 experts in paediatric exercise physiology and physical therapy, mainly from Europe. Recommendations derived from a validated systematic literature review were evaluated by an online survey and subsequently discussed at two consensus meetings using nominal group technique. Recommendations were accepted if >80% agreement was reached. RESULTS: In total, 7 overarching principles, 33 recommendations on diagnosis and 19 recommendations on therapy were accepted with >80% agreement among experts. Topics covered include assessment of skin, muscle and major organ involvement and suggested treatment pathways. CONCLUSIONS: The SHARE initiative aims to identify best practices for treatment of patients suffering from PRD. Within this remit, recommendations for the diagnosis and treatment of JDM have been formulated by an evidence-informed consensus process to produce a standard of care for patients with JDM throughout Europe.
650    _2
$a cyklosporin $x terapeutické užití $7 D016572
650    _2
$a dermatomyozitida $x diagnóza $x terapie $7 D003882
650    _2
$a Evropa $7 D005060
650    _2
$a medicína založená na důkazech $7 D019317
650    12
$a terapie cvičením $7 D005081
650    _2
$a glukokortikoidy $x terapeutické užití $7 D005938
650    _2
$a lidé $7 D006801
650    _2
$a imunosupresiva $x terapeutické užití $7 D007166
650    _2
$a methotrexát $x terapeutické užití $7 D008727
650    _2
$a kyselina mykofenolová $x terapeutické užití $7 D009173
650    _2
$a týmová péče o pacienty $x organizace a řízení $7 D010348
650    12
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a prednisolon $x terapeutické užití $7 D011239
650    _2
$a rituximab $x terapeutické užití $7 D000069283
650    _2
$a společnosti lékařské $7 D012955
650    _2
$a přípravky chránící proti slunci $x terapeutické užití $7 D013473
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bader-Meunier, Brigitte $u Department for Immunology, Hematology and Pediatric Rheumatology, Necker Hospital, APHP, Institut IMAGINE, Paris, France.
700    1_
$a Baildam, Eileen $u Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
700    1_
$a Constantin, Tamas $u 2nd Department of Pediatrics, Semmelweis Hospital, Budapest, Hungary.
700    1_
$a Dolezalova, Pavla $u Paediatric Rheumatology Unit, Department of Paediatrics and Adolescent Medicine, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Praha, Czech Republic.
700    1_
$a Feldman, Brian M $u Division of Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
700    1_
$a Lahdenne, Pekka $u Department of Pediatric Rheumatology, Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland.
700    1_
$a Magnusson, Bo $u Paediatric Rheumatology Unit, Astrid Lindgren Children's Hospital, Karolinska University Hospital Stockholm, Sweden.
700    1_
$a Nistala, Kiran $u Centre for Adolescent Rheumatology, Institute of Child Health University College London, London, UK.
700    1_
$a Ozen, Seza $u Department of Paediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
700    1_
$a Pilkington, Clarissa $u Centre for Adolescent Rheumatology, Institute of Child Health University College London, London, UK.
700    1_
$a Ravelli, Angelo $u Università degli Studi di Genova and Istituto Giannina Gaslini, Genoa, Italy.
700    1_
$a Russo, Ricardo $u Service of Immunology and Rheumatology, Hospital de Pediatría Garrahan, Buenos Aires, Argentina.
700    1_
$a Uziel, Yosef $u Department of Paediatrics, Meir Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
700    1_
$a van Brussel, Marco $u Division of Pediatrics, Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
700    1_
$a van der Net, Janjaap $u Division of Pediatrics, Child Development and Exercise Center, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
700    1_
$a Vastert, Sebastiaan $u Department of Pediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
700    1_
$a Wedderburn, Lucy R $u Centre for Adolescent Rheumatology, Institute of Child Health University College London, London, UK.
700    1_
$a Wulffraat, Nicolaas $u Department of Pediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
700    1_
$a McCann, Liza J $u Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
700    1_
$a van Royen-Kerkhof, Annet $u Department of Pediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
773    0_
$w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 76, č. 2 (2017), s. 329-340
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27515057 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170720124046 $b ABA008
999    __
$a ok $b bmc $g 1239462 $s 984694
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 76 $c 2 $d 329-340 $e 20160811 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...